Atlas FDA

SENOCLAIRE

FDA premarket approval P130020 · decided 2014-08-26

Approval details

PMA number
P130020
Trade name
SENOCLAIRE
Generic name
Digital breast tomosynthesis
Applicant
GE Healthcare
Date received
2013-07-17
Decision date
2014-08-26
Days to decision
405 days
Decision code
APPR
Product code
OTE
Advisory committee
Radiology
Expedited review
No
Location
Waukesha, WI
Statement
APPROVAL FOR THE SENOCLAIRE. THIS DEVICE IS INDICATED FOR THE ACQUISITION OF 2D IMAGES AND ALSO FOR THE ACQUISITION OF MULTIPLE PROJECTION VIEWS INTENDED TO PRODUCE 3D DBT IMAGES SUITABLE FOR SCREENING AND DIAGNOSIS OF BREAST CANCER. SENOCLAIRE CAN BE USED FOR THE SAME CLINICAL APPLICATIONS AS TRADITIONAL MAMMOGRAPHY FOR SCREENING MAMMOGRAPHY. A SCREENING EXAMINATION WILL CONSIST OF:1) 2D IMAGE SET CONSISTING OF A CRANIOCAUDAL VIEW AND OF A MEDIOLATERAL OBLIQUE VIEW, OR 2) A 2D CRANIOCAUDAL VIEW

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
View (K253639)GE Healthcare2026-01-08
MR Contour DL (K242925)GE Healthcare2025-04-01
Digital Expert Access with Remote Scanning (K232346)GE Healthcare2023-10-27
Precision DL (K223212)GE Healthcare2023-04-27
Xeleris V Processing and Review System (K221680)GE Healthcare2023-03-01
Omni Legend (K221932)GE Healthcare2022-09-02
Voluson P6, Voluson P8 (K213689)GE Healthcare2022-02-17
Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert (K213642)GE Healthcare2022-01-13